Investors

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Parnell Pharmaceuticals Holdings’s financial performance into perspective.

Press Releases

Events & Presentations


Oct 14, 2019
Parnell Pharmaceuticals Holdings Ltd Announces New CDMO Agreement and Business Update

Jun 7, 2019
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Quarter Ended 31 March 2019

Apr 30, 2019
Notice of Annual General Meeting and Explanatory Memorandum

May 30, 2017 at 4:00 PM CT
Parnell Pharmaceuticals Holdings Ltd Annual General Meeting

May 24, 2017 at 5:00 PM ET
Parnell Pharmaceuticals Holding Ltd Business Update
Investors and analysts may access the conference call by dialing (877) 244-6184 (U.S./Canada) or (920) 663-6271 (International) and using the conference ID# 27440696

View all press releases >>

View all events & presentations >>

To
Top